Project Grant HT94252310259
Award Date
9/25/23
Completion Date
9/24/27
Dollars Obligated
$4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Richmond, VA 23284, USA
Similar Awards
This $1,971,886 project grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research exploring the impact of microprocessor-controlled knees on prosthesis awareness and overall health. Virginia Commonwealth University is the primary awardee and will work with sub-awardees Hanger, Inc. and the University of Washington on this research from July 2021 through June 2025. The grant aims to transform military and...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and...
The Department of Defense's Defense Health Agency awarded a $623,003 Project Grant to Virginia Commonwealth University (VCU) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from May 1, 2024 to April 30, 2027, will fund a longitudinal study to characterize the genetic architecture and risk factors for post-concussive symptoms, post-traumatic stress disorder, and alcohol use disorder in a military cohort. VCU has subawarded a portion of the grant to...
The federal Project Grant award of $5,954,349.00, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a randomized controlled trial to optimize heart rate variability treatment for combat veterans and service members with persistent post-concussion symptoms. The primary awardee, Virginia Commonwealth University, will collaborate with sub-awardees Palo Alto Veterans Institute For Research and Richmond Institute For Veterans...
The Department of Defense's Defense Health Agency awarded Virginia Commonwealth University (VCU) a $568,461 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "READING HISTONE H2A UBIQUITINATION IN THE FUNCTION OF RSF1 IN BREAST CANCERS WITH RSF1 GENE AMPLIFICATION." The grant, effective from March 1, 2024 through February 28, 2027, will fund VCU's research to advance the scientific understanding of breast cancer and develop...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $249,732 in funding to Virginia Commonwealth University (VCU) for research on novel kappa opioid receptor (KOR) agonists and their potential to promote central nervous system (CNS) repair. The award, which runs from September 1, 2024 to August 31, 2025, will enable VCU to conduct research aimed at developing effective treatments for...
Virginia Commonwealth University was awarded a two-year, $232,875 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research titled "GLT-1/EAAT2: A NOVEL PLAYER IN MYELIN REPAIR" being conducted between September 30, 2022 and September 29, 2024 in Richmond, Virginia. Through this funding, VCU researchers will investigate medical solutions for the battlefield by exploring the...
This $4,734,035 Project Grant awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports Virginia Commonwealth University (VCU) in developing nerve tape for gap management. The 4-year award, which began on September 30, 2024, will fund research, development, and testing of this innovative medical technology to address neurological injuries and disorders that impact military service members and veterans. As a leading...
The Virginia Commonwealth University will receive $1.5 million over four years from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to manage distress in malignant brain cancer. Through this Project Grant award issued on August 1, 2021 and concluding on July 31, 2025, VCU will provide services to transform healthcare for service members and the public through innovative research investigating medical solutions for the...